Correlation Between Dyne Therapeutics and Inventiva
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Inventiva Sa, you can compare the effects of market volatilities on Dyne Therapeutics and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Inventiva.
Diversification Opportunities for Dyne Therapeutics and Inventiva
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dyne and Inventiva is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Inventiva go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Inventiva
Considering the 90-day investment horizon Dyne Therapeutics is expected to under-perform the Inventiva. In addition to that, Dyne Therapeutics is 1.94 times more volatile than Inventiva Sa. It trades about -0.02 of its total potential returns per unit of risk. Inventiva Sa is currently generating about 0.11 per unit of volatility. If you would invest 248.00 in Inventiva Sa on August 25, 2024 and sell it today you would earn a total of 13.50 from holding Inventiva Sa or generate 5.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. Inventiva Sa
Performance |
| Timeline |
| Dyne Therapeutics |
| Inventiva Sa |
Dyne Therapeutics and Inventiva Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and Inventiva
The main advantage of trading using opposite Dyne Therapeutics and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
| Inventiva vs. Mineralys Therapeutics, Common | Inventiva vs. Eliem Therapeutics | Inventiva vs. Anebulo Pharmaceuticals | Inventiva vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |